Dunggon, Reyman -.

HRN: 27-50-96  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/04/2025
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
08/04/2025
08/11/2025
ORAL
4ml
Q8H
Hematoma Forehead Sec To Fall
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueEye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines